MORF-627 is a selective, orally active inhibitor for integrin alphavbeta6 with an IC50 of 9.2 nM measuring by human serum ligand binding assay. MORF-627 inhibits alphavbeta6-mediated TGF-beta1 activation with an IC50 of 2.63 nM, inhibits SMAD2/3 phosphorylation with an IC50 of 8.3 nM. MORF-627 ameliorates the Bleomycin (HY-108345)-induced mouse lung fibrosis[1].
Molekulargewicht:
537.67
CAS Nummer:
[2412688-16-3]
Formel:
C31H40FN3O4
Target-Kategorie:
Integrin,TGF-beta/Smad
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten